NCT03072199View on ClinicalTrials.gov

Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

May 1, 2021

Conditions
Ischemic Heart DiseaseMyocardial InfarctionInflammation
Interventions
DRUG

RiTUXimab Injection

Single dose of Rituximab given intravenously within 48hours of myocardial infarction

Trial Locations (1)

CB23 3RE

Papworth Hospital NHS Trust, Cambridge

All Listed Sponsors
lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT03072199 - Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study | Biotech Hunter | Biotech Hunter